CLASS II Device recall · Reported 2 Aug 2017 · FDA Enforcement Report

Pacific Hemostasis FDP Latex Reagent recalled by Fisher Diagnostics

Fisher Diagnostics is recalling Pacific Hemostasis FDP Latex Reagent, distributed nationwide in the US. The recall was initiated on 19 May 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Number 890199, Exp. 6/30/2018
Quantity recalled27 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2763-2017
FDA event ID
77340
Recalling firm
Fisher Diagnostics, Middletown, VA
Classification
Class II
Status
Terminated
Recall initiated
19 May 2017
FDA classified
25 Jul 2017
Reported
2 Aug 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

19 May 2017Recall initiated by company
25 Jul 2017Classified by FDA+67 days
2 Aug 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

An issue was discovered with the Pacific Hemostasis Fibrinogen Degradation Products (FDP) kit, list number 100650, lot 948546 and FDP Latex Reagent, list 100651, lot 890199. While the kit performs accurately at FDP concentrations greater than 20 ¿g/ml, there is an observed reduction in sensitivity when FDP levels are less than 20 ¿g/ml. This reduction in sensitivity has been tied to FDP Latex Reagent lot 890199 and may result in false negatives.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Pacific Hemostasis FDP Latex Reagent, REF/Model Number 100651, UDI 00845275000870, 1 x 5 mL, IVD; --- Fisher Diagnostics, a division of Fisher Scientific Company, LLC, a part of Thermo Fisher Scientific Inc., Middletown, VA 22645-1905 USA

Where it was distributed

USA (nationwide) including Puerto Rico, and Internationally to Colombia

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

An issue was discovered with the Pacific Hemostasis Fibrinogen Degradation Products (FDP) kit, list number 100650, lot 948546 and FDP Latex Reagent, list 100651, lot 890199. While the kit performs accurately at FDP concentrations greater than 20 ¿g/ml, there is an observed reduction in sensitivity when FDP levels are less than 20 ¿g/ml. This reduction in sensitivity has been tied to FDP Latex Reagent lot 890199 and may result in false negatives.

Which lots are affected?

Lot Number 890199, Exp. 6/30/2018

Where was it sold?

USA (nationwide) including Puerto Rico, and Internationally to Colombia

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 77340

This product is part of a recall event; the main page for the event is Pacific Hemostasis FDP (Fibrinogen Degradation Products) recalled.

More recalls from Fisher Diagnostics

All 4

Other Test Kits & Diagnostics recalls

All 2,656